Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce that it has submitted the Clinical Study Report to the U.S. Food ...
Gum disease may impair brain function, potentially increasing the risk of Alzheimer’s disease, a new study finds.Researchers compared MRI brain scans of 51 adul ...